Your Pocket Guide Is Ready — Human Oversight of AI in Hea...

Human Oversight of AI in Healthcare:
What ISO 42001 Clause 8 Actually Requires

Your 20–25 page PDF guide is available below. Print the evidence checklist section (Part 4) before your next governance committee meeting.

Bookmark this page. To re-download any time within 30 days, re-enter your email above. If you lose access, email support@unuslondon.com with your order reference and the relevant product code in the subject line.

Getting Started

How to Use This Guide Effectively

Read Part 1 first — understand the accountability problem before the clause

The regulatory context section (Part 1) explains why Clause 8 exists and how ISO 42001, EU AI Act Article 14, and CQC Well-Led converge on the same evidence requirement. Read this before the clause breakdown — it frames every sub-clause in terms of the clinical accountability question it is answering, which makes the technical requirements significantly easier to apply.

Use Clause 8.5 to draft your oversight procedure

The Clause 8.5 section is the operational core of the guide. Work through it with the person who will draft your human oversight procedure — typically your Quality Manager or Governance Lead. The sub-clause specifies everything the procedure shall contain. The guide tells you what each component means in your clinical setting. Together, they produce the specification from which the procedure is written.

Print Part 4 — the 32-item checklist — before your next governance committee

Part 4 is formatted to be printed on A4 and completed by hand in a governance committee session. Work through each of the 32 items and mark: ✓ (in place), ~ (partially in place), or ✗ (absent). The 12 CQC inspection-critical items are flagged — if your committee has limited time, focus on those 12 first. The completed checklist is a dated governance committee record — retain it as evidence of systematic AI governance review.

Use Part 3 to brief your legal team on EU AI Act exposure

Part 3 extracts the Article 14 obligations that apply specifically to deployers — healthcare organisations using third-party AI. Use this section to brief your legal adviser or trust solicitor on the EU AI Act exposure your organisation may have, and to have an informed conversation about whether your clinical AI systems fall within Annex III high-risk scope. The guide prepares you for that conversation; it does not replace qualified legal advice.

Follow the 90-day plan in Part 5 — assign owners before closing the guide

Part 5 sequences implementation across three 30-day phases. Before you close the guide, assign an owner and target date to each Phase 1 action. The Phase 1 actions are the minimum set required to close the CQC inspection-critical items from Part 4. Phase 2 builds the monitoring and incident management structure. Phase 3 embeds the continual improvement loop. Without ownership assigned, the plan stays a plan.

Implementation Reference

Your 90-Day Implementation Summary

Full sequencing and detail is in Part 5 of the guide. This summary is for quick reference.

Phase 1 — Days 1–30

Close the Inspection-Critical Gaps

Appoint named AI System Owner for each clinical AI system

Draft and approve Human Oversight Procedure (Cl. 8.5)

Train all clinical staff who interact with AI systems on the procedure

Establish override record format and confirm recording mechanism

Complete operational impact assessment for each AI system in clinical use (Cl. 8.2)

Phase 2 — Days 31–60

Build the Monitoring Structure

Define AI performance indicators (minimum: override rate, concordance rate)

Establish AI incident trigger criteria integrated with PSIRF

Set quarterly AI performance governance committee review as standing agenda item

Document AI system operation record (Cl. 8.4) for each system

Conduct Article 14 scope check — confirm whether any system is Annex III high-risk

Phase 3 — Days 61–90

Embed Continual Improvement

Conduct first quarterly AI oversight review — review override records, identify patterns

Update oversight procedure based on override record findings

Set AI system objective targets (Cl. 8.3) based on first quarter performance data

Integrate AI governance evidence into annual quality report

Schedule next annual operational impact assessment (Cl. 8.2) and set calendar reminder

Checklist Preview

Part 4 — 32-Item Evidence Checklist (Sample)

The first 8 items of the 32-item checklist are shown below. Items marked CQC CRITICAL are the 12 items most likely to be examined during a CQC Well-Led inspection. Print the full checklist (Part 4 of your PDF) for your governance committee session.

PG-AIMS-HC-001 · Part 4 — Evidence Checklist · Clause 8 Human Oversight

32-Item Pre-Inspection Evidence Checklist (sample: items 1–8 of 32)

Section 1 — Oversight Authority Structure (Clause 8.5) — Items 1–6

A Human Oversight Procedure document exists for each AI system in clinical use — the document has a reference number, version, approval date, and approving authorityCQC Critical

A named AI System Owner is designated for each clinical AI system — their authority to override AI outputs is documented within the oversight procedureCQC Critical

The oversight procedure specifies the minimum clinical competency required to review AI outputs for each system — this competency is measurable and assessableStandard

All clinical staff who interact with AI systems have read and understood the oversight procedure — training completion records exist and are currentCQC Critical

The override procedure is documented in the oversight procedure — it specifies what must be recorded when an AI recommendation is not followed by a clinicianCQC Critical

Override records are maintained and accessible — the records can be produced for a CQC inspector or for PSIRF investigation within 24 hoursCQC Critical

Section 2 — Operational Impact Assessment (Clause 8.2) — Items 7–10

An operational impact assessment has been conducted for each AI system currently in clinical use — this is a separate document from the pre-deployment risk assessmentCQC Critical

The operational impact assessment identifies the patient population affected, the nature and frequency of AI influence on clinical decisions, and the actual (not projected) consequences observed since deploymentStandard

Items 9–32 are in your downloaded PDF (Part 4) · Print at A4 for governance committee use

ISO 42001 × CQC Well-Led Framework — Healthcare Series

The Pocket Guide Closes Gap 8. The Integration Guide Closes All Nine.

You now have the deepest available treatment of the highest-risk gap. The next step — when you're ready — is the full Integration Guide: all nine ISO 42001 gaps mapped against every CQC KLoE, with a 12-month Unified Governance Calendar.

Free✓ 5 CQC AI Governance Gaps — you have this

£19✓ Gap Severity Matrix — you have this (or purchase separately)

£47✓ Human Oversight Pocket Guide — you have this

£167Integration Guide — Complete ISO 42001 × CQC Well-Led dual-framework mapping. 8 intersection chapters. 12-month Unified Governance Calendar. 50–70pp. For Directors of Quality.

See the Integration Guide — £167 → Or access the full series at the Governance Academy — £97/month · 7-day free trial · unuslondon.com/academy

Support

Questions or Access Issues?

Content Questions

Questions about Clause 8 or Article 14

For questions about applying the guide's content to your specific clinical context, post in the Governance Academy community or email directly.

Governance Academy Community →

Download Access

Can't access the file or lost the link?

Email your order reference with "PG-AIMS-HC-001 resend" in the subject. We resend access within one business day.

support@unuslondon.com →

Refund requests handled through order's 60-day guarantee — order.com/support

Human Oversight of AI in Healthcare:What ISO 42001 Clause 8 Actually Requires

Your download links